The functional impact of the relatively dephosphorylated state of HMGCR in NASH patients was confirmed by a significant increase in circulating desmosterol/cholesterol ratios compared to controls (p < 0.01) [28]. Here, HMGCR is linked to metabolic dysfunction-associated steatohepatitis.